June 23, 2022 12:25 PM EDT
FDA+
Manufacturing

FDA warns Mex­i­can glyc­erin man­u­fac­tur­er for re­fus­ing an in­spec­tion

Tyler Patchen

News Reporter

A drug man­u­fac­tur­ing fa­cil­i­ty in Mex­i­co is draw­ing the ire of the FDA af­ter it ig­nored the US reg­u­la­tor’s in­spec­tion re­quests and phone calls. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Se­nior As­traZeneca ex­ec de­tained in Chi­na amid wider in­ves­ti­ga­tion

Avid Bioser­vices to be sold to pri­vate eq­ui­ty firms for $1.1B

Pfiz­er to in­vest $1B in Chi­na over next five years — re­ports

Soft RSV sales re­veal a vac­cine mar­ket fail­ing to catch post-Covid mo­men­tum

Stephen Squin­to's JPM life sci­ences team is rais­ing a new fund for lat­er-stage com­pa­nies

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times